Day 10 Post-Prescription Audit Optimizes Antibiotic Therapy in Patients with Bloodstream Infections.
antimicrobial stewardship
bacteremia
medical audit
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
23 Jul 2020
23 Jul 2020
Historique:
received:
03
06
2020
revised:
16
07
2020
accepted:
17
07
2020
entrez:
29
7
2020
pubmed:
29
7
2020
medline:
29
7
2020
Statut:
epublish
Résumé
This study aimed to investigate the clinical and organizational impact of an active re-evaluation (on day 10) of patients on antibiotic treatment diagnosed with bloodstream infections (BSIs). A prospective, single center, pre-post quasi-experimental study was performed. Patients were enrolled at the time of microbial BSI confirmation. In the pre-intervention phase (August 2014-August 2015), clinical status and antibiotic regimen were re-evaluated at day 3. In the intervention phase (January 2016-January 2017), clinical status and antibiotic regimen were re-evaluated at day 3 and day 10. Primary outcomes were rate of optimal therapy, duration of antibiotic therapy, length of hospitalization, and 30-day mortality. A total of 632 patients were enrolled (pre-intervention period,
Identifiants
pubmed: 32717827
pii: antibiotics9080437
doi: 10.3390/antibiotics9080437
pmc: PMC7459471
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Curr Infect Dis Rep. 2018 Jun 29;20(9):31
pubmed: 29959545
Clin Infect Dis. 2013 Nov;57(9):1237-45
pubmed: 23899684
Pharmacotherapy. 2018 Jun;38(6):674-687
pubmed: 29679383
J Hosp Med. 2018 Jan 25;13(5):336-342
pubmed: 29370318
JAMA Intern Med. 2016 Sep 1;176(9):1257-65
pubmed: 27455166
J Clin Microbiol. 2014 Oct;52(10):3558-67
pubmed: 25031441
Int J Antimicrob Agents. 2009;34 Suppl 4:S47-51
pubmed: 19931818
Clin Infect Dis. 2013 Feb;56(4):527-35
pubmed: 23087397
JAMA Intern Med. 2017 Aug 1;177(8):1130-1138
pubmed: 28459929
Intensive Care Med. 2019 Feb;45(2):172-189
pubmed: 30659311
Eur J Clin Microbiol Infect Dis. 2019 May;38(5):977-983
pubmed: 30924012
Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):167-173
pubmed: 29052092
Lancet Infect Dis. 2017 Sep;17(9):990-1001
pubmed: 28629876
N Engl J Med. 2015 May 21;372(21):1996-2005
pubmed: 25992746
Clin Infect Dis. 2018 Aug 1;67(4):525-532
pubmed: 29790913
Braz J Infect Dis. 2016 May-Jun;20(3):255-61
pubmed: 27094234
Eur J Clin Microbiol Infect Dis. 2019 May;38(5):851-857
pubmed: 30680566
Infect Control Hosp Epidemiol. 2014 Sep;35(9):1092-9
pubmed: 25111916
Crit Care Med. 2014 Aug;42(8):1749-55
pubmed: 24717459
Clin Infect Dis. 2016 May 15;62(10):e51-77
pubmed: 27080992
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Lancet. 2012 Aug 4;380(9840):484-90
pubmed: 22726802
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
J Clin Microbiol. 2016 Mar;54(3):576-84
pubmed: 26677254
PLoS One. 2012;7(8):e41290
pubmed: 22952580
Pediatr Infect Dis J. 2016 Oct;35(10):1104-10
pubmed: 27254036
Clin Infect Dis. 2018 Jan 6;66(2):172-177
pubmed: 29190320
Arch Pathol Lab Med. 2013 Sep;137(9):1247-54
pubmed: 23216247
Antimicrob Agents Chemother. 2013 Mar;57(3):1150-6
pubmed: 23254436
Am J Clin Pathol. 2008 Dec;130(6):870-6
pubmed: 19019762
PLoS One. 2018 Mar 28;13(3):e0194858
pubmed: 29590188
Clin Infect Dis. 2009 Jul 1;49(1):1-45
pubmed: 19489710
Urology. 2008 Jan;71(1):17-22
pubmed: 18242357
Open Forum Infect Dis. 2018 Nov 22;5(12):ofy314
pubmed: 30555853
Clin Infect Dis. 2019 Jan 7;68(2):239-246
pubmed: 29901775
Infection. 2017 Oct;45(5):613-620
pubmed: 28478600
Braz J Infect Dis. 2015 May-Jun;19(3):246-52
pubmed: 25892314
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30803971
Lancet Infect Dis. 2016 Sep;16(9):999-1000
pubmed: 27684337
Lancet Infect Dis. 2016 Jul;16(7):847-856
pubmed: 26947617
Clin Infect Dis. 2017 Mar 1;64(5):537-543
pubmed: 27927861
Clin Infect Dis. 2019 Sep 13;69(7):1091-1098
pubmed: 30535100
JAMA. 2016 Sep 20;316(11):1193-1204
pubmed: 27654605